Results 301 to 310 of about 336,976 (335)

913 Familial liver adenomatosis associated with hepatocyte nuclear factor 1 alpha inactivation

Hepatology, 2003
C. Balabaud, Yannick Bacq, Sophie Branchereau, Danièle Pariente, Christophe Laurent, B Scotto, Emmanuel Jacquemin, P Bourlier, A. DeMuret, Emmanuelle Jeannot   +9 more
openaire   +2 more sources

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Current treatment and recent progress in gastric cancer

Ca-A Cancer Journal for Clinicians, 2021
Smita S Joshi, Brian D Badgwell
exaly  

An Optimized Protocol of Electroporation of Hepatocyte Nuclear Factor 1 Alpha (Hnf-1α) in Mesenchymal Stem Cells

Cytology and Genetics
Sumreen Begum, Sehrish Jabeen, Syed Adibul Hasan Rizvi   +2 more
semanticscholar   +1 more source

Erratum to: An Optimized Protocol of Electroporation of Hepatocyte Nuclear Factor 1 Alpha (Hnf-1α) in Mesenchymal Stem Cells

Cytology and Genetics
Sumreen Begum, Sehrish Jabeen, Syed Adibul Hasan Rizvi   +2 more
semanticscholar   +1 more source

Living Donor Liver Transplantation for Hepatocyte Nuclear Factor 1 Homeobox Alpha (HNF1A)-inactivated Hepatocellular Adenoma in Pediatric Patient

HPB
Young Seok Han, J. Han
semanticscholar   +1 more source

912 REGULATION OF THE HUMAN UDP-GLUCURONOSYLTRANSFERASE UGT1A7 BY HEPATOCYTE NUCLEAR FACTOR 1 ALPHA (HNF1 ALPHA) AND HEPATOCYTE NUCLEAR FACTOR 4 ALPHA (HNF4 ALPHA)

Journal of Hepatology, 2008
Sandra Kalthoff, M.P. Manns, Thomas J. Erichsen, Tim O. Lankisch, Nicole Freiberg, Christian P. Strassburg, Ursula Ehmer   +6 more
openaire   +2 more sources

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Comparative analysis of Napsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 279 ovarian tumours

Pathology (Sydney), 2015
O. Fadare, Chengquan Zhao, D. Khabele, V. Parkash, C. Quick, K. Gwin, M. Desouki   +6 more
semanticscholar   +1 more source

Evolving standards of care and new challenges in the management of HER2‐positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Ciara C O’sullivan, Grace D Cullen, Grace M Choong   +2 more
exaly